Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Free Cash Flow over the past 9 years, most recently at -$6.0 million for Q4 2023.

  • For Q4 2023, Free Cash Flow rose 19.41% year-over-year to -$6.0 million; the TTM value through Dec 2023 reached -$36.1 million, up 3.88%, while the annual FY2024 figure was -$41.8 million, 15.77% down from the prior year.
  • Free Cash Flow for Q4 2023 was -$6.0 million at Corbus Pharmaceuticals Holdings, up from -$7.2 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $10.2 million in Q1 2019 and troughed at -$28.1 million in Q1 2020.
  • A 5-year average of -$13.5 million and a median of -$13.7 million in 2022 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: soared 457.22% in 2019 and later plummeted 945.44% in 2022.
  • Year by year, Free Cash Flow stood at -$23.9 million in 2019, then grew by 23.82% to -$18.2 million in 2020, then soared by 46.31% to -$9.8 million in 2021, then rose by 23.59% to -$7.5 million in 2022, then grew by 19.41% to -$6.0 million in 2023.
  • Business Quant data shows Free Cash Flow for CRBP at -$6.0 million in Q4 2023, -$7.2 million in Q3 2023, and -$7.8 million in Q2 2023.